Slow vital capacity as a useful indicator of the prognosis after percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis
- PMID: 35975358
- DOI: 10.1111/ane.13683
Slow vital capacity as a useful indicator of the prognosis after percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis
Abstract
Objectives: Forced vital capacity (FVC) is recommended as a respiratory function test in patients with amyotrophic lateral sclerosis (ALS). However, in ALS associated with orofacial palsy, FVC may be an unreliable test. Slow vital capacity (SVC) is an easier and more reliable test even in cases with bulbar symptoms. However, it remains unclear whether respiratory function tests using SVC and FVC are associated with prognosis after percutaneous endoscopic gastrostomy (PEG) placement. This study aimed to confirm whether both SVC and FVC are related to prognosis after PEG placement in patients with ALS.
Materials and methods: We conducted this retrospective observational cohort study of 69 consecutive patients diagnosed with sporadic ALS who underwent PEG placement between July 2007 and February 2020. We analyzed the association with mortality 6 months after PEG placement and evaluated long-term prognosis.
Results: Forty-four patients met the inclusion criteria. In cases with decreased SVC (p < .01) and FVC (p < .01), a significant difference was observed in mortality 6 months after PEG placement, with an optimal cut-off of SVC ≤57.4% (sensitivity, 0.828; specificity, 0.867) and FVC ≤57.3% (sensitivity, 0.828; specificity, 0.867). Multivariate analysis showed that onset age ≥ 65 years (p < .05), SVC ≤57.4% (p < .01), and FVC ≤57.3% (p < .01) were associated with survival after PEG placement.
Conclusions: SVC, like FVC, is an important prognostic factor after PEG placement in patients with ALS, and there is a possibility that evaluation using SVC can complement respiratory function testing even in cases where the evaluation of FVC is limited.
Keywords: amyotrophic lateral sclerosis; forced vital capacity; percutaneous endoscopic gastrostomy; prognosis; slow vital capacity.
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis?Amyotroph Lateral Scler. 2012 Oct;13(6):550-4. doi: 10.3109/17482968.2012.684215. Epub 2012 Jun 18. Amyotroph Lateral Scler. 2012. PMID: 22708872
-
An analysis of prognostic factors after percutaneous endoscopic gastrostomy placement in Japanese patients with amyotrophic lateral sclerosis.J Neurol Sci. 2017 May 15;376:202-205. doi: 10.1016/j.jns.2017.03.029. Epub 2017 Mar 21. J Neurol Sci. 2017. PMID: 28431613
-
Correlation between Forced Vital Capacity and Slow Vital Capacity for the assessment of respiratory involvement in Amyotrophic Lateral Sclerosis: a prospective study.Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):86-91. doi: 10.1080/21678421.2016.1249486. Epub 2016 Dec 4. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 27915482
-
Ethical considerations in the management of amyotrophic lateral sclerosis.Prog Neurobiol. 2013 Nov;110:45-53. doi: 10.1016/j.pneurobio.2013.05.001. Epub 2013 Jun 2. Prog Neurobiol. 2013. PMID: 23735671 Review.
-
[Nutritional approach for patients with amyotrophic lateral sclerosis].Rev Neurol (Paris). 2006 Jun;162 Spec No 2:4S177-4S187. Rev Neurol (Paris). 2006. PMID: 17128108 French.
Cited by
-
Timing and impact of percutaneous endoscopic gastrostomy insertion in patients with amyotrophic lateral sclerosis: a comprehensive analysis.Sci Rep. 2024 Mar 26;14(1):7103. doi: 10.1038/s41598-024-56752-5. Sci Rep. 2024. PMID: 38531942 Free PMC article.
References
REFERENCES
-
- Goutman SA. Diagnosis and clinical management of amyotrophic lateral sclerosis and other motor neuron disorders. Continuum (Minneapolis, Minn). 2017;23:1332-1359.
-
- Barone M, Viggiani MT, Introna A, et al. Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:490-496.
-
- Pena MJ, Ravasco P, Machado M, et al. What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis? Amyotroph Lateral Scler. 2012;13:550-554.
-
- ProGasStudyGroup. Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study. Lancet Neurol. 2015;14:702-709.
-
- Bond L, Ganguly P, Khamankar N, et al. A comprehensive examination of percutaneous endoscopic gastrostomy and its association with amyotrophic lateral sclerosis patient outcomes. Brain Sci. 2019;9:223.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous